Netherlands· NL-f82d7d7dd4c0
Ebvallo 5×10E7 cellen/ml, dispersie voor injectie
A tabelecleucel product containing tabelecleucel, registered in Netherlands by Pierre Fabre Medicament. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tabelecleucel is registered in 11 of 19 countries.
Countries holding a registration under ATC L01XL09 (tabelecleucel), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Tabelecleucel · ATC L01XL09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TABELECLEUCEL
- Manufacturer
- Pierre Fabre Medicament
- Country
- Netherlands (NL)
- ATC code
- L01XL09
- ATC class
- Tabelecleucel
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/22/1700
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tabelecleucel in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEbvallo 2.8 10*7 cells/ml - 7.3 10*7 cells/mlPierre Fabre Médicament
- SwitzerlandEbvallo, InjektionsdispersionPierre Fabre Pharma SA
- CzechiaEBVALLOPIERRE FABRE MEDICAMENT, Lavaur
- SpainEBVALLO 2,8 × 10E7 - 7,3 × 10E7 CÉLULAS /ML DISPERSION INYECTABLEPierre Fabre Medicament
- FinlandEbvalloPierre Fabre Medicament
- FranceEBVALLO 2,8 x 10 000 000 - 7,3 x 10 000 000 cellules/mL, dispersion injectablePIERRE FABRE MEDICAMENT
- IrelandEbvallo 2.8 × 10^7 – 7.3 × 10^7 cells/mL dispersion for injectionPierre Fabre Medicament
- IcelandEbvalloPierre Fabre Medicament
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ebvallo
- Liechtenstein · Ebvallo
- Norway · Ebvallo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59178ee6-b7fb-402c-b3fc-a66597c91902 GET /v1/drugs/59178ee6-b7fb-402c-b3fc-a66597c91902?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersie voor injectie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ebvallo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Tabelecleucel",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129226",
"excipients": [
"DIMETHYLSULFOXIDE",
"FOSFAATGEBUFFERDE ZOUTOPLOSSING ZONDER CALCIUM EN MAGNESIUM",
"HUMAAN ALBUMINE OPLOSSING"
],
"substances": [
"TABELECLEUCEL"
],
"leaflet_url": null,
"authorised_at": "2022/12/16",
"procedure_number": "EMEA/H/C/004577",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1700",
"additional_monitoring": "Y"
}See everything about tabelecleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.